Kamat A M, Lamm D L
Department of Urology, West Virginia University School of Medicine, Morgantown, USA.
J Urol. 1999 Jun;161(6):1748-60.
Cancer is a major cause of mortality and morbidity throughout the world, and ranks as the second leading cause of death in the United States. Most cancers have a latent period of 10 to 20 years, which provides ample time for preventive measures. Transitional cell carcinoma of the bladder and adenocarcinoma of the prostate have protracted courses and may be ideal for chemopreventive strategies. We review the biochemistry and epidemiology of chemopreventive agents, and the laboratory and clinical studies of their role in urological cancer.
We performed a computerized MEDLINE search and manual bibliographical review of relevant peer reviewed studies and reports from 1966 to 1998. These reports were analyzed and scrutinized, and the important findings are summarized.
Neoplastic lesions of the bladder and prostate are uniquely suited to the development and evaluation of chemopreventive agents. Epidemiological reports provide the strongest evidence of a protective role for dietary agents in cancer of the bladder, prostate and kidney. Observational and recent experimental trials support these findings in cases of adenocarcinoma of the prostate and transitional cell carcinoma of the bladder. There is strong evidence for a protective effect of vitamin A in bladder cancer. Superior protection has been reported with a combination of high doses of vitamins A, B6, C and E plus zinc. For prostate cancer strong evidence exists for a preventive effect of reduced fat intake, vitamin E, selenium and soy proteins. A lesser benefit is also suggested with intake of vitamins D and C. Evidence of chemoprevention against renal cell cancer is supported mainly by epidemiological studies, and animal studies indicate possible benefit of vitamin D supplementation.
Although there is no incontrovertible proof, numerous studies implicate dietary and nutritional factors in the onset and progression of cancer of the bladder, prostate and kidney. It is possible that the preventive effect of dietary constituents may be in part from consumption with other nutrients and bioactive compounds in whole foods. Further research is needed before vitamins and other nutritional supplements can be advocated as standard therapy but the preponderance of evidence supports increased intake of vitamins A, B6, C, D and E, reduction of animal fat, and increased consumption of fruits and vegetables.
癌症是全球死亡和发病的主要原因,在美国是第二大死因。大多数癌症有10至20年的潜伏期,这为预防措施提供了充足时间。膀胱移行细胞癌和前列腺腺癌病程迁延,可能是化学预防策略的理想对象。我们综述化学预防剂的生物化学和流行病学,及其在泌尿生殖系统癌症中作用的实验室和临床研究。
我们对1966年至1998年相关的同行评议研究和报告进行了计算机化的MEDLINE检索及手工文献回顾。对这些报告进行了分析和审查,并总结了重要发现。
膀胱和前列腺的肿瘤性病变特别适合化学预防剂的开发和评估。流行病学报告提供了最有力的证据,表明饮食因素对膀胱癌、前列腺癌和肾癌具有保护作用。观察性研究和近期的实验性试验支持了前列腺腺癌和膀胱移行细胞癌病例中的这些发现。有强有力的证据表明维生素A对膀胱癌有保护作用。据报道,高剂量的维生素A、B6、C和E加锌联合使用具有更好的保护作用。对于前列腺癌,有强有力的证据表明减少脂肪摄入、维生素E、硒和大豆蛋白具有预防作用。摄入维生素D和C也显示出较小的益处。化学预防肾细胞癌的证据主要由流行病学研究支持,动物研究表明补充维生素D可能有益。
尽管没有确凿证据,但大量研究表明饮食和营养因素与膀胱癌、前列腺癌和肾癌的发生及进展有关。饮食成分的预防作用可能部分源于与全食物中其他营养素和生物活性化合物一起摄入。在将维生素和其他营养补充剂作为标准疗法提倡之前,还需要进一步研究,但大量证据支持增加维生素A、B6、C、D和E的摄入量,减少动物脂肪摄入,并增加水果和蔬菜的消费。